DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Australia
  • /
  • Healthcare
Author Program NEWCreate Narrative
IME logo

ImExHS Limited Stock Price

ASX:IME Community·AU$15.2m Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

IME Share Price Performance

AU$0.28
0.02 (5.66%)
​
AU$1.04
Fair Value
AU$0.28
0.02 (5.66%)
73.1% undervalued intrinsic discount
AU$1.04
Fair Value
Price AU$0.28
Wobbegong AU$1.04
AnalystConsensusTarget AU$0.37
Wed, 18 Feb 26
Fair ValueAU$1.04
Share Pricen/a

IME Community Narratives

WO
Wobbegong's
Fair Value
·
Fair Value AU$1.04 73.1% undervalued intrinsic discount

Plenty of upside

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value AU$0.37 24.3% undervalued intrinsic discount

Cloud Adoption And AI Integration Will Support A Stronger Long Term Outcome

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
IME logo
ImExHS
73.1% undervalued intrinsic discount

Plenty of upside

View narrative
WO
Wobbegong
Published 1 Feb
Read Narrative
IME logo
ImExHS
24.3% undervalued intrinsic discount

Cloud Adoption And AI Integration Will Support A Stronger Long Term Outcome

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Sep
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

WO
IME logo

Plenty of upside

Fair Value: AU$1.04 73.1% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
IME logo

IME: Updated Outlook Will Balance Softer Margins With Higher Future Multiple

Fair Value: AU$0.37 24.3% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

2 Risks
2 Rewards
View Full Analysis

ImExHS Limited Key Details

AU$31.3m

Revenue

AU$16.3m

Cost of Revenue

AU$15.0m

Gross Profit

AU$14.8m

Other Expenses

AU$188.6k

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.0035
47.89%
0.60%
1.4%
View Full Analysis

About IME

Founded
2001
Employees
290
CEO
German Arango
WebsiteView website
www.imexhs.com

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists’ interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.

Recent IME News & Updates

User avatar
Narrative Update • Sep 03

IME: Updated Outlook Will Balance Softer Margins With Higher Future Multiple

Analysts have updated their view on ImExHS, trimming the implied fair value estimate while applying a slightly lower discount rate, softer revenue growth and profit margin assumptions, and a much higher future P/E. Together these adjustments point to a more cautious but still constructive price target in A$ terms.

Recent updates

No updates

ImExHS Limited Competitors

DOC logo

Doctor Care Anywhere Group

Symbol: ASX:DOC
Market cap: AU$40.3m
CC5 logo

Clever Culture Systems

Symbol: ASX:CC5
Market cap: AU$39.3m
EYE logo

Nova Eye Medical

Symbol: ASX:EYE
Market cap: AU$38.5m
CBL logo

Control Bionics

Symbol: ASX:CBL
Market cap: AU$33.7m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide